Farringdon Capital’s HCA Healthcare HCA Stock Holding History

Farringdon Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,362	Closed	-$1.1M	–	471
2025 Q4	$1.1M	Buy	+2,362	New	+$1.1M	0.27%	111

Other funds holding HCA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Farringdon Capital's HCA Position: Q1 2026 in Review

Farringdon Capital sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 2,362 shares — an estimated $1.1M sold.

Farringdon Capital first reported a position in HCA in Q4 2025 and held it in 1 quarter. The position peaked at $1.1M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

Farringdon Capital reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
Farringdon Capital sold 2,362 HCA Healthcare shares in Q1 2026, an estimated $1.1M.
Farringdon Capital first reported a position in HCA Healthcare in Q4 2025 and held it in 1 quarter.
Farringdon Capital's HCA Healthcare position peaked at $1.1M in Q4 2025.
1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.